Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Tucker

Showing results (121-130 of 137) with videos related to

Pageof 14
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|February 1, 2019
Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human TrialChristina U Lorentz, Norah G Verbout, Michael Wallisch, et al.
Journal of Thrombosis and Haemostasis : JTH|May 31, 2022
Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosisKelley R Jordan, Cory R Wyatt, Meghan E Fallon, et al.
Blood|August 19, 2024
Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivoCristina Puy, Samantha A Moellmer, Jiaqing Pang, et al.
Blood|January 25, 2020
The protein C activator AB002 rapidly interrupts thrombus development in baboonsErik I Tucker, Norah G Verbout, Brandon D Markway, et al.
Blood|July 17, 2010
A role for factor XIIa-mediated factor XI activation in thrombus formation in vivoQiufang Cheng, Erik I Tucker, Meghann S Pine, et al.
Blood|January 11, 2014
Factor XII inhibition reduces thrombus formation in a primate thrombosis modelAnton Matafonov, Philberta Y Leung, Adam E Gailani, et al.
Blood|June 4, 2021
The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trialChristina U Lorentz, Erik I Tucker, Norah G Verbout, et al.
Blood Advances|October 25, 2019
Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT miceToshiaki Shirai, Alexey S Revenko, Justin Tibbitts, et al.
The Journal of Biological Chemistry|December 20, 2024
The physicochemical properties of lipopolysaccharide chemotypes regulate activation of the contact pathway of blood coagulationAndré L Lira, Berk Taskin, Cristina Puy, et al.
Blood Advances|February 28, 2019
Inhibition of contact-mediated activation of factor XI protects baboons against <i>S aureus</i>-induced organ damage and deathRobert Silasi, Ravi Shankar Keshari, Cristina Lupu, et al.
Pageof 14

Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Arteriosclerosis, Thrombosis, and Vascular Biology|February 1, 2019
Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human TrialChristina U Lorentz, Norah G Verbout, Michael Wallisch, et al.
Journal of Thrombosis and Haemostasis : JTH|May 31, 2022
Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosisKelley R Jordan, Cory R Wyatt, Meghan E Fallon, et al.
Blood|August 19, 2024
Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivoCristina Puy, Samantha A Moellmer, Jiaqing Pang, et al.
Blood|January 25, 2020
The protein C activator AB002 rapidly interrupts thrombus development in baboonsErik I Tucker, Norah G Verbout, Brandon D Markway, et al.
Blood|July 17, 2010
A role for factor XIIa-mediated factor XI activation in thrombus formation in vivoQiufang Cheng, Erik I Tucker, Meghann S Pine, et al.
Blood|January 11, 2014
Factor XII inhibition reduces thrombus formation in a primate thrombosis modelAnton Matafonov, Philberta Y Leung, Adam E Gailani, et al.
Blood|June 4, 2021
The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trialChristina U Lorentz, Erik I Tucker, Norah G Verbout, et al.
Blood Advances|October 25, 2019
Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT miceToshiaki Shirai, Alexey S Revenko, Justin Tibbitts, et al.
The Journal of Biological Chemistry|December 20, 2024
The physicochemical properties of lipopolysaccharide chemotypes regulate activation of the contact pathway of blood coagulationAndré L Lira, Berk Taskin, Cristina Puy, et al.
Blood Advances|February 28, 2019
Inhibition of contact-mediated activation of factor XI protects baboons against <i>S aureus</i>-induced organ damage and deathRobert Silasi, Ravi Shankar Keshari, Cristina Lupu, et al.
Pageof 14